RIPA Virtual Lunch & Learn

Wednesday, August 26, 2026 | 12:00 PM
Live via Zoom
Audience: Pharmacists and Pharmacy Technicians
Presented by: Brian Mastrianni, Novo Nordisk

Recent changes in Medicare coverage have created a new pathway for eligible patients to access GLP-1 therapy through the Medicare GLP-1 Bridge Program—but many patients and healthcare professionals may still be unfamiliar with how the program works.

Join the Rhode Island Pharmacists Association (RIPA) for a practical virtual Lunch & Learn with Brian Mastrianni of Novo Nordisk. This session will pair insights from patient polling data with a step-by-step walkthrough of the Medicare GLP-1 Bridge Program, giving pharmacy professionals the information they need to better understand the program and help patients navigate the process.

During this session, attendees will learn about:

• The purpose and structure of the Medicare GLP-1 Bridge Program

• The patient journey from prescribing through program access

• Clinical eligibility criteria and key program requirements

• Important nuances and considerations pharmacy professionals should know

• Common questions that may arise when helping patients navigate the program

Time will also be reserved for live Q&A, giving pharmacists and pharmacy technicians an opportunity to ask practical questions about the program and its implementation.

Format: Virtual via Zoom
Date: Wednesday, August 26, 2026
Time: 12:00 PM
Duration: Approximately 45–60 minutes

Bring your lunch and join RIPA for a timely, practical discussion designed to help Rhode Island pharmacy professionals better understand this new Medicare access pathway.